Cancer Screening

A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse

Cancer screening delays need immediate attention to avoid a surge in late-stage diagnoses

New synthetic immunohistochemistry reference standards could enable semiquantitative tumor analysis for emerging immunotherapies

Patients with high levels of PD-L2 may benefit from immunotherapy

Patients who carry certain germline mutations have a twofold increased risk of developing cancer in both breasts

New blood test could lead to more affordable cancer detection at earlier stages

Download this application note to learn how you can leverage functional proteomics to reveal unique multi-omic signatures and insights into oncology

Researchers describe the impact of epigenetics on cancer treatment and early detection

The new protocol approximately tripled the rate of patient compliance with recommended genetic testing

The risk of overdiagnosis is a hudtle to general screening that could be overcome with this new pathway